Abstract C160: New Class of DNA-alkylating Agents with a Suitable Tolerability Profile Created for Use in Antibody-Drug Conjugates (Adcs).
Molecular cancer therapeutics（2013）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined